人C反应蛋白对小鼠致命性肺炎链球菌感染具有保护作用。 - Suppr

Suppr

超能文献

Human C-reactive protein is protective against fatal Streptococcus pneumoniae infection in mice.

作者信息

Yother J, Volanakis J E, Briles D E

出版信息

J Immunol. 1982 May;128(5):2374-6.

PMID:7061864

Abstract

摘要

相似文献

Human C-reactive protein is protective against fatal Streptococcus pneumoniae infection in mice.人C反应蛋白对小鼠致命性肺炎链球菌感染具有保护作用。

J Immunol. 1982 May;128(5):2374-6.

Blood clearance of Streptococcus pneumoniae by C-reactive protein.C反应蛋白对肺炎链球菌的血液清除作用。

J Immunol. 1987 Apr 15;138(8):2598-603.

Human C-reactive protein is protective against fatal Streptococcus pneumoniae infection in transgenic mice.人C反应蛋白对转基因小鼠的致命性肺炎链球菌感染具有保护作用。

J Immunol. 1995 Sep 1;155(5):2557-63.

[Protective effect of human C-reactive protein Streptococcus pneumoniae infection in mice].

Nihon Saikingaku Zasshi. 1983;38(2):557-63.

Enhanced protective immunity against pneumococcal infection with PspA DNA and protein.肺炎球菌表面蛋白A（PspA）DNA和蛋白增强对肺炎球菌感染的保护性免疫

Vaccine. 2006 Jul 17;24(29-30):5755-61. doi: 10.1016/j.vaccine.2006.04.046. Epub 2006 May 4.

Immunization of humans with recombinant pneumococcal surface protein A (rPspA) elicits antibodies that passively protect mice from fatal infection with Streptococcus pneumoniae bearing heterologous PspA.用重组肺炎球菌表面蛋白A（rPspA）对人类进行免疫接种可引发抗体，这些抗体可被动保护小鼠免受携带异源PspA的肺炎链球菌的致命感染。

J Infect Dis. 2000 Dec;182(6):1694-701. doi: 10.1086/317602. Epub 2000 Nov 8.

Serum samples from infants vaccinated with a pneumococcal conjugate vaccine, PncT, protect mice against invasive infection caused by Streptococcus pneumoniae serotypes 6A and 6B.接种肺炎球菌结合疫苗PncT的婴儿的血清样本可保护小鼠免受6A和6B型肺炎链球菌引起的侵袭性感染。

J Infect Dis. 2001 Jan 15;183(2):253-260. doi: 10.1086/317934. Epub 2000 Dec 8.

Protection against fulminant sepsis in splenectomized mice by implantation of autochthonous splenic tissue.通过植入自体脾组织对脾切除小鼠暴发性败血症的保护作用。

Exp Hematol. 1978 May;6(5):433-9.

Protection of mice against fatal pneumococcal challenge by immunization with pneumococcal surface adhesin A (PsaA).通过用肺炎球菌表面黏附素A（PsaA）免疫来保护小鼠免受致命的肺炎球菌攻击。

Microb Pathog. 1996 Jul;21(1):17-22. doi: 10.1006/mpat.1996.0038.

Enhancement of Streptococcus pneumoniae serotype 6B infection in mice after passive immunization with human serum.用人血清被动免疫后小鼠肺炎链球菌6B型感染的增强

Microb Pathog. 1996 Aug;21(2):125-37. doi: 10.1006/mpat.1996.0048.

引用本文的文献

Protection against prolonged pneumococcal infection involves structural changes in C-reactive protein and subsequent binding to both phosphocholine and amyloids on the bacterial surface.对肺炎球菌长期感染的防护涉及C反应蛋白的结构变化以及随后与细菌表面的磷酸胆碱和淀粉样蛋白的结合。

Front Immunol. 2025 Jul 16;16:1631409. doi: 10.3389/fimmu.2025.1631409. eCollection 2025.

C-reactive protein: structure, function, regulation, and role in clinical diseases.C 反应蛋白：结构、功能、调节以及在临床疾病中的作用。

Front Immunol. 2024 Jun 14;15:1425168. doi: 10.3389/fimmu.2024.1425168. eCollection 2024.

C-reactive protein - My perspective on its first half century, 1930-1982.C-反应蛋白——我对其前半个世纪（1930-1982 年）的看法。

Front Immunol. 2023 Mar 2;14:1150103. doi: 10.3389/fimmu.2023.1150103. eCollection 2023.

Characterization of the innate immune response to Streptococcus pneumoniae infection in zebrafish.斑马鱼中肺炎链球菌感染的固有免疫反应特征。

PLoS Genet. 2023 Jan 9;19(1):e1010586. doi: 10.1371/journal.pgen.1010586. eCollection 2023 Jan.

Deficiency of C-reactive protein or human C-reactive protein transgenic treatment aggravates influenza A infection in mice.缺乏 C-反应蛋白或人 C-反应蛋白转基因治疗可加重小鼠流感 A 感染。

Front Immunol. 2022 Oct 6;13:1028458. doi: 10.3389/fimmu.2022.1028458. eCollection 2022.

C-Reactive Protein Controls IL-23 Production by Human Monocytes.C 反应蛋白通过人单核细胞控制白细胞介素-23 的产生。

Int J Mol Sci. 2021 Oct 28;22(21):11638. doi: 10.3390/ijms222111638.

Therapeutic Lowering of C-Reactive Protein.C 反应蛋白的治疗性降低

Front Immunol. 2021 Jan 29;11:619564. doi: 10.3389/fimmu.2020.619564. eCollection 2020.

C-Reactive Protein-Based Strategy to Reduce Antibiotic Dosing for the Treatment of Pneumococcal Infection.基于 C 反应蛋白的策略来减少抗生素剂量以治疗肺炎球菌感染。

Front Immunol. 2021 Jan 20;11:620784. doi: 10.3389/fimmu.2020.620784. eCollection 2020.

Treatment of Pneumococcal Infection by Using Engineered Human C-Reactive Protein in a Mouse Model.利用工程化人 C 反应蛋白在小鼠模型中治疗肺炎球菌感染。

Front Immunol. 2020 Oct 7;11:586669. doi: 10.3389/fimmu.2020.586669. eCollection 2020.

Complement Activation by C-Reactive Protein Is Critical for Protection of Mice Against Pneumococcal Infection.C 反应蛋白通过补体激活对保护小鼠免受肺炎球菌感染至关重要。

Front Immunol. 2020 Aug 13;11:1812. doi: 10.3389/fimmu.2020.01812. eCollection 2020.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验